'Hypoallergenic,' 'Dermatologist Tested,' 'Clinically Proven': What Each Phrase Is Allowed to Mean

The Food and Drug Administration has no federal definition for "hypoallergenic." In cosmetics, the word means whatever a company wants it to mean. The same regulatory silence surrounds "dermatologist tested" and "clinically proven"—three phrases that cost consumers extra while promising protections that U.S. Law does not require, verify, or standardize.

"Hypoallergenic" Has No Federal Definition

The FDA states plainly that there are no federal standards or definitions governing "hypoallergenic" in cosmetics. A manufacturer can print the word on a moisturizer, a mascara, or a baby shampoo without submitting any substantiation to the agency. The FDA knows of no scientific studies showing that products labeled this way actually cause fewer adverse reactions than competing conventional products. The term, in the agency's own formulation, "means whatever a particular company wants it to mean."

This emptiness is not a regulatory oversight. It reflects how cosmetics are classified under U.S. Law. Unlike drugs, cosmetics do not undergo pre-market approval. The FDA does not maintain a list of approved or accepted label claims. A company can introduce a "hypoallergenic" lotion tomorrow morning without demonstrating reduced allergenicity to any government body. The only constraint is the broad requirement that labeling must be truthful and not misleading—a standard enforced reactively, through warning letters or court action, not through pre-market review.

Consumers searching for safety should look past the marketing term. Under the Fair Packaging and Labeling Act, cosmetics sold at retail must carry a complete ingredient declaration. The FDA regulates this labeling under both the Federal Food, Drug, and Cosmetic Act and the Fair Packaging and Labeling Act. The ingredient list, not the front-panel promise, is where the concrete information lives.

What the Panel Can Say Instead

The FDA's guidance on allergens in cosmetics explicitly advises consumers not to rely on terms like "hypoallergenic," "fragrance-free," or "for sensitive skin." The agency offers no alternative vocabulary because no substitute marketing phrase would solve the underlying problem: without substantiation requirements, any claim is only as good as the evidence behind it.

Cosmetic labeling must be truthful. The law does not require FDA approval before products reach shelves. The agency does not review claims in advance. A company can assert that its product is "gentle," "pure," or "natural" under the same loose constraints. The difference with "hypoallergenic" is that it sounds medical. Consumers read it as a promise of reduced risk. The FDA's public statements are designed to puncture that expectation.

The ingredient declaration offers something the marketing language cannot: specificity. Preservatives, fragrances, and botanical extracts appear in order of concentration. Someone with a diagnosed allergy to methylisothiazolinone or a sensitivity to limonene can scan for known triggers. The "hypoallergenic" label offers no such precision.

"Dermatologist Tested" Is a People Claim, Not a Result Claim

The phrase "dermatologist tested" suggests professional validation. What it actually asserts is narrower. The FDA has not published a definition of the term in its cosmetics guidance. The legal meaning is not defined in the agency's public materials. From the available record, the phrase implies only that a dermatologist was involved in some aspect of product development or evaluation. It does not guarantee that the product was found safe, non-irritating, or suitable for sensitive skin.

Without federal standards specifying study design, sample size, or endpoints, the claim floats free of measurable content. One company might mean that a single dermatologist glanced at the formula. Another might mean that a dermatologist supervised a patch test on twenty volunteers. A third might mean something else entirely. The consumer cannot tell from the label, and the FDA does not require disclosure of the underlying method.

The Federal Trade Commission regulates advertising claims for cosmetics, including claims made on labels. The FTC's general standard requires health-related advertising to be truthful, not misleading, and supported by competent and reliable scientific evidence. Whether "dermatically tested" meets that standard depends on what was actually done and whether the implied safety benefit matches the evidence. The phrase alone commits to little.

"Clinically Proven" Should Be Treated as an Evidence Claim

"Clinically proven" sounds decisive. In cosmetics, it is not a defined regulatory category. Like other cosmetic claims, it is subject to the general requirement that labeling be truthful and not misleading. The burden of substantiation falls on the company making the claim. The FDA does not review the supporting studies in advance.

The gap between the promise and the proof can be wide. A "clinical" study might involve a handful of subjects in an uncontrolled setting. "Proven" might mean that consumers reported feeling more moisturized, not that a measured clinical endpoint was achieved. The claim does not require peer-reviewed publication. It does not require that the study design be disclosed on the label or in advertising. A consumer encountering "clinically proven" has no immediate way to know what was tested, against what control, for how long, and with what result.

The FTC's substantiation standard—competent and reliable scientific evidence—applies here. But enforcement is retrospective. A company can market on a thin study until challenged. The phrase functions as a bet that most shoppers will not ask what "clinical" meant in this specific case.

The Check That Matters

The practical defense against empty label claims is already required by law. Cosmetics must carry an ingredient declaration. Consumers with known sensitivities can scan for specific compounds. Those without diagnosed allergies can still use the list to compare products and spot patterns in what does or does not irritate their skin.

For marketing claims, the relevant question is not what the label says but what evidence supports it. A "dermatologist tested" product that describes the testing methodology in detail—number of subjects, duration, endpoints measured—offers more than the same phrase standing alone. A "clinically proven" claim tied to a disclosed study, with accessible results, carries more weight than the unadorned assertion. "Hypoallergenic" backed by nothing should be treated as exactly that: a word with no defined meaning, requiring no verification, and promising nothing specific that U.S. Regulators can enforce.

The FDA has published no model language for honest cosmetic claims. It does not suggest alternatives to these three phrases because the regulatory framework treats them as marketing, not as medical assertions. The consumer's task is to read past the front panel to the ingredient list, and past the label to the substantiation, if any, that the company is willing to disclose.

What Skin costs 40 priced entries · prices as recorded

• $0–$1017
• $10–$2518
• $25–$505
• $50–$1000
• $100 and up0

Least expensiveFull Body Sponge$4.99

Most expensiveFace Glow Collection$35

Median here is $12.99 against $24.99 across the whole catalogue.